https://www.dw.com/en/astrazeneca-germany-other-european-countries-to-resume-use-of-vaccine/a-56922088

* *

We use cookies to improve our service for you. You can find more
information in our data protection declaration.

More info OK

 1. Inhalt
 2. Navigation
 3. Weitere Inhalte
 4. Metanavigation
 5. Suche
 6. Choose from 30 Languages

 

  * Albanian Shqip
  * Amharic 'amaarenyaa
  * Arabic l`rby@
  * Bengali baaNlaa
  * Bosnian B/H/S
  * Bulgarian B'lgarski
  * Chinese (Simplified) Jian 
  * Chinese (Traditional) Fan 

  * Croatian Hrvatski
  * Dari dry
  * English English
  * French Francais
  * German Deutsch
  * Greek Ellenika
  * Hausa Hausa
  * Hindi hindii

  * Indonesian Indonesia
  * Kiswahili Kiswahili
  * Macedonian Makedonski
  * Pashto pStw
  * Persian frsy
  * Polish Polski
  * Portuguese Portugues do Brasil
  * Portuguese Portugues para Africa

  * Romanian Romana
  * Russian Russkii
  * Serbian Srpski/Srpski
  * Spanish Espanol
  * Turkish Turkce
  * Ukrainian Ukrayins'ka
  * Urdu rdw

 
Wrong language? Change it here DW.COM has chosen English as your
language setting.
DW.COM in 30 languages
DW AKADEMIE
ABOUT DW
DW.COM
Deutsche Welle
Deutsche Welle
[                    ]
  * TOP STORIES
      + Germany
          o Berlin Wall
      + Coronavirus
      + World
          o Europe
          o Africa
              # Crime Fighters
              # The 77 Percent
              # Africa on the Move
          o Asia
          o Americas
          o Middle East
      + Business
          o Founders Valley
          o Wo+men
          o My 2030
      + Science
      + Environment
          o Global Ideas
              # DoingYourBit
          o Eco Africa
          o Living Planet
      + Culture
          o Film
          o Books
          o Music
          o Arts
          o Digital Culture
          o Lifestyle
          o Travel
          o BTHVN2020
      + Sports

    SPECIAL

      + 100 Must-Reads
      + 50 kitchens, one city
      + Baking Bread
      + DW Freedom
      + Expedition Humboldt
      + Gutenberg in the Cyberstorm
      + Meet the Germans
      + Planet Berlin
  * Media Center
      + Live TV
      + All media content
      + Latest Programs
      + Podcasts
  * TV
      + Schedule and Reception
      + TV Programs

    TV programs

      + Arts.21
      + Arts and Culture
      + Business
      + Check-in
      + Close up
      + Conflict Zone
      + DocFilm
      + DW News
      + Eco Africa
      + Eco India
      + Euromaxx
      + Faith Matters
      + Focus on Europe
      + Global 3000
      + In Good Shape
      + Kick off!
      + Made in Germany
      + Reporter
      + REV
      + Shift
      + Sports Life
      + The Day
      + The 77 Percent
      + Tomorrow Today
      + To the Point
      + World Stories
  * RADIO
  * LEARN GERMAN

    German Courses

      + German Courses
      + Quick start
      + Harry
      + Deutsch Interaktiv
      + Radio D
      + Mission Europe
      + Deutsch - warum nicht?
      + Audiotrainer
      + Deutschtrainer
      + Die Bienenretter

    German XXL

      + German XXL
      + Deutsch Aktuell
      + Deutsch im Fokus
      + Telenovela
      + Bandtagebuch
      + Landeskunde

    Community D

      + Community D
      + Das Portrat
      + Podcasts & Newsletter
      + Service

    Teaching German

      + Teaching German
      + DW im Unterricht
      + Unterrichtsreihen
      + Deutschlehrer-Info

  * Germany
  * Coronavirus
  * World
  * Business
  * Science
  * Environment
  * Culture
  * Sports

TOP STORIES
Advertisement

News

AstraZeneca: Germany, other European countries to resume use of
vaccine

Germany, France and several other European countries have decided to
lift suspensions on the AstraZeneca coronavirus vaccine following
safety guidance from the European Medicines Agency.

        

A vial of AstraZeneca's coronavirus vaccine

Several EU countries had halted the use of the AstraZeneca vaccine
over concerns about potential links to blood clotting

Germany, France and several other EU countries on Thursday have
decided to continue using the AstraZeneca vaccine after the European
Medicines Agency (EMA) deemed the shot "safe and effective."

Germany will resume administering the jab on Friday, according to
Health Minister Jens Spahn. The vaccine, however, will come with new
advice on potential side effects.

"The common aim of the federal government and all 16 states is for
vaccinations with AstraZeneca to start tomorrow," Spahn said. Germany
had previously suspended the vaccine as a precaution, with Spahn
vowing to make a decision on the vaccine after EMA guidance. 

"The EMA analysis has confirmed the action we took," Spahn
continued. "It was right to suspend vaccinations as a precaution
until the accumulation of cases with this very rare type of
thrombosis could be analyzed."

Watch video 02:52

EMA: AstraZeneca vaccine safe and effective

Where do other European countries stand?

France, Italy, Latvia, Bulgaria and Slovenia will also move forward
with the AstraZeneca vaccine following the EMA's guidance. French
Prime Minister Jean Castex plans to receive the AstraZeneca shot on
Friday to boost public confidence in the vaccine. 

"The AstraZeneca COVID-19 vaccine is effective, as underlined by the
European regulator. It only has relatively rare side effects," Castex
said.

Italian Prime Minister Mario Draghi said AstraZeneca vaccinations
will "resume tomorrow," adding that "the government's priority is to
carry out as many vaccinations as possible in the shortest possible
time." 

Spain will reintroduce AstraZeneca vaccinations on Wednesday, but
will exclude some demographic groups to minimize health risks. 

Lithuania will resume using the AstraZeneca jab on Friday, according
to Health Minister Arunas Dulkys. Dulkys will join Lithuania's
president, prime minister and parliamentary speaker on Monday in
getting the AstraZeneca vaccine.

Watch video 04:33

Share

AstraZeneca vaccine gets the green light

Send Facebook Twitter reddit EMail Facebook Messenger Web Whatsapp
Web Telegram linkedin

Permalink https://p.dw.com/p/3qq9u

AstraZeneca vaccine gets the green light

Norway, Sweden to wait for now

Norway and Sweden will keep the AstraZeneca vaccine suspended as
their public health bodies assess the situation. 

"Vaccinations with AstraZeneca will remain suspended until we have a
full view of the situation," Norwegian Institute of Public Health
director Camilla Stoltenberg told reporters, saying it was
"premature" to come to a final conclusion on the vaccine. 

Sweden has said it "needs a few days" before coming to a decision on
the jab. 

 

Audios and videos on the topic

Several European countries suspend AstraZeneca vaccine  

AstraZeneca stop: What does the data say?  

  * Date 18.03.2021
  * Author Wesley Dockery
  * Related Subjects Germany, France, Coronavirus vaccine
  * Keywords AstraZeneca, Germany, France
  * Send us your feedback.
  * Print Print this page
  * Permalink https://p.dw.com/p/3qq2C

Advertisement

News

US and China trade barbs as Alaska talks kick off 4m ago

Coronavirus digest: US to send first vaccine exports to Mexico,
Canada 1h ago

AstraZeneca: Germany, other European countries to resume use of
vaccine 2h ago

Russia holds Afghan peace summit amid push for ceasefire 2h ago

Nord Stream 2: US warns companies to 'immediately abandon work' 3h
ago

Facebook Offizielles Logo

DW News on Facebook 11.07.2017

Twitter Offizielles Logo

Follow @dwnews on Twitter 11.07.2017

  * TOP STORIES
  * Germany
  * Coronavirus
  * World
  * Business
  * Science
  * Environment
  * Culture
  * Sports
  *  
  * A - Z Index

  * MEDIA CENTER
  * Live TV
  * All media content
  * Latest Programs
  * Podcasts

  * TV
  * Schedule and Reception
  * TV Programs
  *  
  * RADIO

  * LEARN GERMAN
  * German Courses
  * German XXL
  * Community D
  * Teaching German

  * ABOUT DW
  * Who we are
  * Press
  * GMF
  * Business & Sales
  * Advertising
  * Travel

  * SERVICE
  * Reception
  * Apps & Co.
  * Newsletters & Co.
  * FAQ
  * Contact
  *  
  * DW AKADEMIE
  * About us
  * Media Development
  * Master's Degree
  * Traineeship
  * Training

(c) 2021 Deutsche Welle | Privacy Policy | Legal notice | Contact |
Mobile version